Related Experiment Videos
Signaling through Disabled 1 requires phosphoinositide binding.
Yongcheng Huang1, Vaibhav Shah, Tongzheng Liu
1Division of Pharmacology, College of Pharmacy, The Ohio State University, 500 W 12th Avenue, Columbus, OH 43210, USA.
Biochemical and Biophysical Research Communications
|May 11, 2005
Summary
The phosphoinositide-binding region of Disabled 1 (Dab1) is crucial for its membrane localization and phosphorylation, independent of Reelin receptors. This interaction is essential for Dab1
Area of Science:
- Neuroscience
- Cell Biology
- Molecular Biology
Background:
- The Reelin signaling pathway is vital for neuronal positioning during brain development.
- Disabled 1 (Dab1) acts as an intracellular adaptor protein in this pathway.
- Dab1 is tyrosine phosphorylated upon Reelin binding to neuronal surface receptors VLDLR and ApoER2.
Purpose of the Study:
- To investigate the role of the phosphoinositide-binding region within the Dab1 PTB domain.
- To determine the necessity of this region for membrane localization and phosphorylation.
- To elucidate the receptor-independent functions of Dab1 in the Reelin pathway.
Main Methods:
- Analysis of Dab1's phosphoinositide-binding region.
- Assessment of membrane localization and tyrosine phosphorylation of Dab1.
- Investigation of Dab1 interactions with Src and Crk kinases.
- Studies on Reelin-induced phosphorylation in the presence and absence of phosphoinositide binding.
Main Results:
- The phosphoinositide-binding region of Dab1 is essential for its membrane localization and basal tyrosine phosphorylation, independent of VLDLR and ApoER2.
- Receptor-independent membrane targeting of Dab1 is required for its interaction with Src and Crk.
- Disruption of phosphoinositide binding abrogates Reelin-induced tyrosine phosphorylation of Dab1.
Conclusions:
- Dab1's phosphoinositide-binding capability is a critical determinant of its localization and activation.
- This receptor-independent mechanism is fundamental for downstream signaling in the Reelin pathway.
- Targeting Dab1's phosphoinositide interaction offers a potential avenue for modulating Reelin signaling.